Behavioral dermatology

Veterinary Clinics of North America - Small Animal Practice

Volumn 33, Issue 2, 2003, Pages 231-251

  Virga, Vint ^a  

^a Behavioral Medicine for Animals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLOMICALM; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; DOXEPIN; FLUOXETINE; LORAZEPAM; MELATONIN; MONOAMINE OXIDASE INHIBITOR; NALTREXONE; NEUROLEPTIC AGENT; OXAZEPAM; PAROXETINE; PHENOTHIAZINE DERIVATIVE; PSYCHOTROPIC AGENT; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; UNCLASSIFIED DRUG;

ALOPECIA; ANIMAL BEHAVIOR; ANIMAL CARE; AUTOMUTILATION; BEHAVIOR DISORDER; BEHAVIOR MODIFICATION; BEHAVIORAL MEDICINE; CAT; DERMATOLOGY; DIAGNOSTIC APPROACH ROUTE; DOG; DRUG ABSORPTION; DRUG CROSS REACTIVITY; DRUG DOSAGE FORM; DRUG DOSE REGIMEN; DRUG MECHANISM; HUMAN; HYPERESTHESIA; NONHUMAN; PRURITUS; REVIEW; SKIN MANIFESTATION; VETERINARY MEDICINE; ANIMAL; ANIMAL DISEASE; ANXIETY DISORDER; CAT DISEASE; DOG DISEASE; SKIN DISEASE; STEREOTYPY;

ANIMALIA; CANIS FAMILIARIS; FELIS CATUS;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BEHAVIOR, ANIMAL; CAT DISEASES; CATS; DOG DISEASES; DOGS; SKIN DISEASES; STEREOTYPED BEHAVIOR;

EID: 0037356089     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(02)00102-X     Document Type: Review

References (67)

1. Koo JYM, Chantal T. Psychodermatology: practical guidelines on pharmacotherapy. Arch Dermatol 1992;128:381-8.
2. Savin JA, Cotterill JA. Psychocutaneous disorders. In: Champion RH, Burton JL, Ebling FJG, editors. Textbook of dermatology. vol. 4. 5th edition. Oxford: Blackwell Scientific Publications; 1992. p. 2479-96.
3. White SD. Naltrexone for treatment of acral lick dermatitis in dogs. JAVMA 1990;196:1073-6.
4. Panconesi E, Hautman G. Psychophysiology of stress in dermatology. Clin Dermatol 1996;14:399-422.
5. Pert CB, Ruff MR, Weber RJ, et al. Neuropeptides and their receptors: a psychosomatic network. J Immunol 1985;135(Suppl):S820-6.
6. Rassmussen JE. Psychosomatic dermatology. Arch Dermatol 1990;126:90-3.
7. Field TM, Schanberg SM, Scafid F, et al. Tactile kinesthetic stimulation effects on preterm neonates. Pediatrics 1986;77:654-8.
8. Meier GW. Infantile handling and development in Siamese kittens. J Comp Physiol Psychol 1961;54:284-6.
9. Paul J, Kuhn CM, Field TM, et al. Positive effect of tactile and kinesthetic or vestibular stimulation on neuroendocrine and ornithine decarboxylase activity in maternally deprived rat pups. Life Sci 1986;39:2081-7.
10. Solomon GF, Levine S, Kraft JK. Early experience and immunity. Nature 1968;220:821-2.
11. Bar LHJ, Kuypers BRM. Behavioral therapy in dermatological practice. Br J Dermatol 1973;88:591-8.
12. Fried RG. Nonpharmacologic treatments in psychodermatology. Clin Dermatol 2002;20:177-85.
13. Koblenzer CS. Successful treatment of a chronic disabling dermatoses by psychotherapy. J Am Acad Dermatol 1986;15:390-3.
14. Surman OS, Gottleib SK, Hackett TP, et al. Hypnosis in the treatment of warts. Arch Gen Psychiatry 1973;28:439-41.
15. Gupta MA, Gupta AK. Psychodermatology: an update. J Am Acad Dermatol 1996;34:1030-46.
16. Koo JYM, Do JH, Lee CS. Psychodermatology. J Am Acad Dermatol 2000;43:848-53.
17. Koblenzer CS. Cutaneous manifestations of psychiatric disease that commonly present to the dermatologist - diagnosis and treatment. Int J Psychiatry Med 1992;22:47-63.
18. Koo JYM, Lebwohl A. Psychodermatology: the mind and skin connection. Am Fam Physician 2001;64:1873-8.
19. Koblenzer CS. Itching and the atopic skin. J Allergy Clin Immunol 1999;104(Suppl):S109-13.
20. Tobin D, Nabarro G, Baart dela Faille H, et al. Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 1992;90:613-22.
21. Shanley K. Pathophysiology of pruritus. Vet Clin North Am Small Anim Pract 1988;18:971-81.
22. Scheich G, Florin I, Rudolph R, et al. Personality characteristics and serum IgE level in patients with atopic dermatitis. J Psychosom Res 1993;37:637-42.
23. Overall K. Fears, anxieties, and stereotypies. In: Clinical behavioral medicine for small animals. St. Louis: Mosby-Year Book; 1997. p. 209-50.
24. Overall K. Self-injurious behavior and obsessive-compulsive disorder in domestic animals. In: Dodman NH, Shuster L. editors. Psychopharmacology of animal behavior disorders. Malden (MA): Blackwell Science; 1998. p. 222-52.
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994.
26. Luescher UA, McKeown DB, Halip J. Stereotypic or obsessive-compulsive disorders in dogs and cats. Vet Clin North Am Small Anim Pract 1991;21:401-13.
27. Overall K. Terminology in behavioral medicine: necessary and sufficient conditions for behavioral diagnoses. Newsletter of the American Veterinary Society of Animal Behavior 1995;17:3-7.
28. Scott DW, Miller WH, Griffin CE. Psychogenic skin diseases. In: Small animal dermatology. 5th edition. Philadelphia: WB Saunders; 1995. p. 846-58.
29. Shanley KS, Overall KL. Psychogenic dermatoses. In: Kirk RW, Bonagura JD, Current veterinary therapy XI: small animal practice. Philadelphia: WB Saunders; 1992. p. 552-8.
30. Young MS, Manning TO. Psychogenic dermatoses (dog and cat). Dermatol Rep 1994;3:1-8.
31. Moon-Fanelli AA, Dodman NH, O'Sullivan RL. Veterinary models of compulsive self-grooming: parallels with trichotillomania. In: Christenson GA, Stein DJ, Hollander E, editors. Trichotillomania: new developments. Washington, DC: American Psychiatric Press; 1999. p. 63-92.
32. Rappaport JL, Ryland DH, Kriet M. Drug treatment of canine acral lick: an animal model of obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:517-21.
33. Houpt KA. Aggression and social structure. In: Domestic animal behavior for veterinarians and animal scientists. 3rd edition. Ames (IA): Iowa State University Press; 1998. p. 33-81.
34. Eckstein RA, Hart BL. The organization and control of grooming in cats. Appl Anim Behav Sci 2000;68:131-40.
35. Panaman R. Behaviour and ecology of free-ranging female farm cats. Zeitschrift Tierpsychologie 1981;56:59-73.
36. Kenny DE. Use of naltrexone for treatment of psychogenically induced dermatoses in five zoo animals. JAVMA 1994;204:1021-3.
37. Beaver BV. Animal behavior case of the month. JAVMA 1993;203:651-2.
38. Houpt KA. Learning. In: Domestic animal behavior for veterinarians and animal scientists. 3rd edition. Ames (IA): Iowa State University Press; 1998. p. 251-85.
39. Scott DW, Miller WH, Griffin CG. Structure and function of the skin. In: Muller & Kirk's small animal dermatology. 5th edition. Philadelphia: WB Saunders; 1995. p. 1-54.
40. Gupta MA, Gupta AK, Schork NJ, et al. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994;56:36-40.
41. Dahl RE, Bernhisel-Broadbent J, Scanlon-Holford S, Sampson HA, Lupo M. Sleep disturbance in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995;149:856-860.
42. Stores G, Burrows A, Crawford C. Physiologic sleep disturbance in children with atopic dermatitis: a case control study. Pediatr Dermatol 1998;15:264-8.
43. Ginsburg IH, Prystowsky JH, Kornfeld DS, Wolland H. Role of emotional factors in adults with atopic dermatitis. Int J Dermatol 1993;32:656-9.
44. Koo JYM, Gambla C. Cutaneous sensory disorder. Clin Dermatol 1996;14:497-502.
45. Backonja MM, Gaylor BS. Pain assessment and evaluation in patients who have neuropathic pain. Neurol Clin 1998;16:775-89.
46. VanNoorden S, Polak JM, Negri L, et al. Common peptides in the brain, intestine, and skin: embryology, evolution, and significance. J Endocrinol 1997;75:33-4.
47. Dubner R, Bennett GJ. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978;4:451-62.
48. Karlsten R. How do drugs relieve neurogenic pain? Drug Ther 1997;5:398-412.
49. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.
50. Tennyson H, Levine N. Neurotropic and psychotropic drugs in dermatology. Clin Dermatol 2001;19:179-97.
51. Kaplan MD, Sadock BJ. Tricyclics and tetracyclics. In: Pocket handbook of psychiatric drug treatment. 2nd edition. Baltimore: Williams & Wilkins; 1996. p. 170-83.
52. Garnis-Jones S. Dermatologic side effects of psychopharmacologic agents. Clin Dermatol 1996;14:503-8.
53. Overall KL. Use of clomipramine to treat ritualistic stereotypic motor behavior in three dogs. JAVMA 1994;205:1733-41.
54. Kaplan MD, Sadock BJ. Serotonin-specific reuptake inhibitors. In: Pocket handbook of psychiatric drug treatment. 2nd edition. Baltimore: Williams & Wilkins; 1996. p. 146-61.
55. Freeman CPL, Trimble MR, Deakin JFW, et al. Fluvoxamine versus clomipramine in the treatment of obsessive-compulsive disorder: a multi-center, randomized, double blind, parallel group comparison. J Clin Psychiatry 1994;55:301-5.
56. Greist JH, Jefferson JW, Kobak KA, et al. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. Arch Gen Psychiatry 1995;52:53-60.
57. Koo JYM, Gambla C. A psychopharmacology for dermatological patients. Clin Dermatol 1996;14:509-23.
58. Overall K. Behavioral pharmacology. In: Clinical behavioral medicine for small animals. St. Louis: Mosby-Year Book; 1997. p. 293-322.
59. White SD. Management of acral lick dermatitis (ALD, lick granuloma). In: Proceedings of the Fourth World Congress of Veterinary Dermatology, San Francisco. 2000. San Francisco: World Congress of Veterinary Dermatology Association. p. 126-28.
60. Schwartz S. Naltrexone-induced pruritis in a dog with tail-chasing behavior. JAVMA 1993;202:278-80.
61. Nelson RJ. The endocrine system. In: An introduction to behavioral endocrinology. 2nd edition. Sunderland: Sinauer Associates; 2000. p. 35-96.
62. Nelson RJ. Hormones and mood. In: An Introduction to behavioral endocrinology. 2nd edition. Sunderland: Sinauer Associates; 2000. p. 627-58.
63. Aronson L. Animal behavior case of the month. JAVMA 1999;215:22-4.
64. Pierrefiche G, Zerbib R, Laborit H. Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors. Res Commun Chem Pathol Pharmacol 1993;82:131-142.
65. Van Moffaert M. Psychodermatology: an overview. Psychother Psychosom 1992;58:125-136.
66. Mills KC. Serotonin syndrome: a clinical update. Crit Care Clin 1997;13:763-83.
67. Paradis M. Melatonin in canine alopecias. In: Proceedings of the Fourth World Congress of Veterinary Dermatology, San Francisco. 2000. p. 52-9.